bovin
viral
diarrhea
viru
bvdv
pestiviru
member
flavivirida
famili
close
relat
use
surrog
model
hepat
c
viru
envelop
contain
glycoprotein
disulfid
link
homoand
heterodim
studi
investig
role
disulfid
bond
format
fold
assembl
stabil
bvdv
glycoprotein
provid
molecular
evid
intact
disulfid
bond
critic
acquir
stabl
conform
monom
forc
glycoprotein
adopt
reduc
conform
either
coor
posttransl
assembl
dimer
determin
misfold
degrad
proteasom
contrast
dimer
glycoprotein
result
conform
resist
reduc
agent
degrad
furthermor
inhibit
eramannosidas
activ
lead
impair
misfold
degrad
demonstr
involv
enzym
target
viral
protein
toward
proteasom
degrad
bovin
viral
diarrhea
viru
bvdv
pestiviru
member
flavivirida
famili
due
resembl
hepat
c
viru
hcv
hepaciviru
member
famili
bvdv
enjoy
increas
attent
absenc
reliabl
cell
cultur
system
abl
replic
hcv
bvdv
adopt
surrog
model
hcv
especi
studi
focu
infect
bvdv
envelop
posit
singlestrand
rna
viru
genom
encod
singl
polyprotein
precursor
coand
posttransl
process
host
viral
proteas
produc
matur
structur
nonstructur
protein
viru
structur
protein
compris
nucleocapsid
protein
c
three
envelop
glycoprotein
e
rn
unlik
e
rn
lack
transmembran
domain
secret
infect
cell
although
detail
structur
bvdv
known
assum
viral
nucleocapsid
surround
lipid
envelop
contain
glycoprotein
protein
interact
form
heterodimer
complex
propos
function
subunit
matur
virion
interest
differ
bvdv
hcv
may
resid
natur
linkag
protein
within
dimer
bvdv
complex
clearli
shown
disulfid
bond
cell
lysat
matur
virion
purifi
hcv
glycoprotein
complex
express
recombin
system
report
associ
mainli
noncoval
fashion
fraction
present
lysat
cell
infect
vaccinia
virushcv
recombin
shown
associ
via
disulfid
linkag
suggest
part
nonproduct
pathway
lead
misfold
aggreg
previou
studi
follow
fold
bvdv
glycoprotein
show
biochem
biophys
research
commun
wwwacademicpresscom
bbrc
intramolecular
disulfid
bond
form
cotransl
nascent
polypeptid
chain
intermolecular
disulfid
bond
form
later
releas
interact
erchaperon
calnexin
howev
littl
known
role
disulfid
bond
fold
bvdv
envelop
glycoprotein
format
stabl
nativ
complex
paper
address
contribut
disulfid
bond
fold
assembl
bvdv
envelop
glycoprotein
follow
effect
reduc
agent
dithiothreitol
dtt
biosynthesi
stabil
degrad
glycoprotein
uncleav
precursor
studi
show
prevent
format
intramolecular
disulfid
bond
well
reduc
bond
form
determin
misfold
monom
subsequ
degrad
protein
assembl
dimer
conform
becom
resist
dtt
use
proteasom
inhibitor
show
reduc
viral
protein
mainli
degrad
proteasom
process
greatli
impair
inhibitor
ermannosidas
activ
suggest
role
mannos
trim
target
misfold
bvdv
envelop
glycoprotein
proteasom
cell
cultur
viru
noncytopat
bvdvfree
mdbk
cell
european
collect
anim
cell
cultur
porton
uk
grown
rpmi
medium
gibcobrl
supplement
vv
bvdvfree
fetal
calf
serum
paa
laboratori
teddington
uk
uml
penicillin
mgml
streptomycin
life
technolog
cytopath
cp
bvdv
nadl
strain
obtain
american
type
cultur
collect
manassa
va
reagent
antibodi
dithiothreitol
l
methionin
protein
gsepharos
proteas
inhibitor
cocktail
sigma
methioninecystein
tran
slabel
cimmol
methionineand
cysteinefre
rpmi
starvat
medium
icn
flow
thame
oxfordshir
uk
endoplasm
reticulum
er
mannosidas
inhibitor
dmj
proteaseom
inhibitor
nacetyllleucyllleucyllnorleucin
nalln
lactacystin
obtain
sigma
monoclon
antibodi
mab
bvdv
glycoprotein
purchas
veterinari
laboratori
agenc
weybridg
uk
polyclon
antiactin
antibodi
sigma
polyclon
anticalnexin
antibodi
purchas
bioquot
york
uk
antimous
antirabbit
horseradish
peroxidaseconjug
secondari
antibodi
amersham
infect
mdbk
cell
bvdv
mdbk
cell
grown
subconflu
monolay
sixwel
plate
infect
cp
bvdv
multipl
infect
moi
plaqu
form
unit
pfu
cell
h
previous
describ
inoculum
remov
cell
wash
phosphatebuff
salin
pb
incub
continu
h
postinfect
pi
rpmi
medium
cell
treat
differ
inhibitor
detail
figur
legend
harvest
time
indic
lyse
buffer
contain
triton
mm
triscl
ph
mm
nacl
mm
edta
tritonts
buffer
western
blot
protein
separ
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
transfer
nitrocellulos
membran
use
semidri
electroblott
millipor
detect
antibvdv
antibodi
mab
dilut
pb
contain
dri
milk
follow
antimous
antibodi
dilut
conjug
horseradish
peroxidas
experi
detect
actin
calnexin
use
load
control
polyclon
antiactin
anticalnexin
antibodi
use
dilut
protein
detect
use
enhanc
chemiluminesc
detect
system
amersham
accord
manufactur
instruct
pulselabel
chase
subconflu
mdbk
cell
monolay
infect
bvdv
moi
h
incub
viral
inoculum
remov
cell
wash
pb
incub
medium
contain
fetal
calf
serum
eighteen
hour
pi
cell
wash
pb
incub
starvat
buffer
effect
either
proteasom
ermannosidas
inhibitor
analyz
correspond
drug
includ
starvat
buffer
concentr
indic
figur
legend
h
cell
pulselabel
lci
tran
slabel
per
ml
presenc
absenc
mm
dtt
time
indic
figur
follow
label
isotopesuppl
medium
remov
cell
wash
pb
chase
variou
time
rpmi
medium
contain
mm
unlabel
methionin
time
point
indic
figur
mm
dtt
ad
chase
medium
cell
incub
presenc
reduc
agent
variou
time
discard
chase
medium
radioact
label
cell
harvest
lyse
tritonts
buffer
mixtur
proteas
inhibitor
h
ice
experi
associ
bvdv
glycoprotein
disulfidelink
dimer
monitor
mm
iodoacetamid
includ
lysi
buffer
prevent
nonspecif
format
disulfid
bond
aggreg
immunoprecipit
sdspage
label
cell
lysat
clarifi
centrifug
min
preclear
protein
gsepharos
h
lysat
briefli
centrifug
supernat
incub
antibvdv
mab
antibodi
dilut
overnight
protein
gsepharos
ad
supernat
incub
continu
h
slurri
wash
six
time
triton
tse
buffer
immunoprecipit
complex
elut
boil
sampl
min
sdspage
sampl
buffer
presenc
reduc
condit
absenc
nonreduc
condit
follow
sdspage
gel
treat
amplifi
amersham
dri
expos
hyperfilmmp
amersham
intens
band
result
autoradiogram
measur
scan
densitometri
import
event
assembl
pestivirus
thought
format
nativ
heterodim
major
compon
two
pestivirus
classic
swine
fever
viru
csfv
bvdv
complex
begin
associ
intermolecular
disulfid
bond
er
monom
acquir
intramolecular
disulfid
bond
releas
calnexin
explor
role
coand
posttransl
form
disulfid
bond
steadyst
level
bvdv
glycoprotein
express
mdbk
cell
employ
method
describ
sever
laboratori
membran
permeabl
reduc
agent
dtt
use
produc
protein
lack
disulfid
bond
mdbk
cell
grown
monolay
infect
bvdv
five
millimolar
dtt
ad
cell
h
pi
synthesi
viral
protein
allow
proceed
either
presenc
absenc
reduc
agent
h
express
glycoprotein
analyz
sdspage
reduc
condit
follow
western
blot
mab
antibodi
recogn
nonreduc
reduc
form
bvdv
glycoprotein
use
detect
viral
protein
expect
untreat
sampl
glycoprotein
accumul
insid
cell
due
continu
transcript
translat
viral
rna
interestingli
signal
correspond
protein
dtttreat
sampl
decreas
dramat
h
treatment
almost
complet
lost
end
h
incub
period
fig
upper
panel
suggest
either
biosynthesi
glycoprotein
impair
newli
synthes
viral
protein
degrad
presenc
dtt
event
may
contribut
effect
dtttreat
sampl
amount
neither
increas
remain
constant
suggest
viral
protein
present
cell
prior
dtt
incub
also
certain
extent
affect
dtt
treatment
sampl
load
control
detect
solubl
cytoplasmresid
protein
actin
transmembran
erloc
protein
calnexin
perform
western
blot
fig
lower
panel
investig
whether
observ
reduct
amount
bvdv
protein
dtttreat
sampl
could
account
gener
decreas
total
protein
synthesi
label
mdbk
infect
cell
perform
presenc
absenc
reduc
agent
rate
label
amino
acid
incorpor
cellular
protein
affect
minor
extent
dtttreat
sampl
data
shown
recent
shown
bvdv
glycoprotein
acquir
intramolecular
disulfid
bond
cotransl
immedi
translat
complet
determin
exogen
ad
dtt
interfer
format
rapidli
acquir
disulfid
bond
bvdvinfect
mdbk
cell
pulselabel
min
absenc
continu
presenc
dtt
radioact
label
viral
protein
immunoprecipit
use
mab
migrat
sdspage
nonreduc
nr
reduc
r
condit
fig
untreat
dtt
sampl
oxid
glycoprotein
occur
normal
shown
differ
migrat
pattern
nonreduc
reduc
sampl
wherea
protein
puls
presenc
dtt
show
ident
migrat
nonreduc
reduc
condit
strikingli
viral
protein
lost
presenc
dtt
reveal
scan
densitometri
analysi
suggest
prevent
format
disulfid
bond
result
synthesi
unstabl
protein
rapidli
target
degrad
differ
intens
band
correspond
glycoprotein
run
nonreduc
reduc
condit
due
effici
elut
bound
protein
protein
gsepharos
bead
reduc
condit
establish
prevent
disulfid
bond
format
nascent
viral
polypeptid
result
biosynthesi
unstabl
rapidli
degrad
protein
proceed
determin
whether
disulfid
monom
alreadi
fold
would
access
dtt
bvdvinfect
mdbk
cell
pulselabel
min
chase
min
absenc
reduc
agent
allow
normal
fold
format
disulfid
bond
occur
initi
chase
mm
dtt
ad
cell
chase
continu
addit
min
cell
lyse
immunoprecipit
mab
bound
protein
analyz
sdspage
nonreduc
reduc
condit
fig
previous
shown
within
first
min
posttransl
glycoprotein
exist
mainli
form
monom
later
begin
associ
homodim
heterodim
therefor
within
min
posttransl
dtt
treatment
monom
expos
shown
fig
monom
oxid
normal
compar
lane
nr
r
dtt
untreat
sampl
differ
migrat
pattern
protein
nonreduc
reduc
sampl
dtttreat
sampl
suggest
disulfid
bond
monom
access
reduc
dtt
moreov
intens
band
correspond
bvdv
glycoprotein
reduc
approxim
presenc
dtt
compar
untreat
sampl
suggest
reduc
monom
unstabl
conform
therefor
target
degrad
investig
kinet
degrad
extend
chase
h
shown
fig
amount
viral
protein
immunoprecipit
mab
decreas
dramat
throughout
chase
dtttreat
sampl
suggest
reduc
monom
unabl
oligomer
accumul
er
target
degrad
instead
effici
qualiti
control
system
oper
er
ensur
incorrectli
fold
protein
select
target
degrad
proteasom
investig
whether
bvdv
glycoprotein
synthes
presenc
dtt
target
proteasom
follow
effect
two
potent
proteasom
inhibitor
lactacystin
nalln
dttinduc
degrad
glycoprotein
western
blot
analysi
show
proteasom
inhibitor
markedli
block
viral
protein
degrad
lactacystin
greatest
effect
fig
thought
physiolog
condit
degrad
misfold
protein
take
place
certain
delay
synthesi
time
mannos
trim
occur
er
persist
unfold
protein
mark
degrad
howev
degrad
reduc
bvdv
glycoprotein
follow
rather
unpreced
kinet
fig
therefor
attempt
determin
whether
glycan
process
ermannosidas
also
involv
fast
degrad
experi
similar
describ
fig
perform
dmj
use
inhibit
ermannosidas
activ
shown
fig
inhibitor
greatli
suppress
proteasomeassoci
degrad
reduc
protein
confirm
remov
mannos
asparaginelink
oligosaccharid
preced
viral
protein
proteolysi
dimer
glycoprotein
determin
protect
dtt
action
degrad
dtt
ad
either
cotransl
immedi
monom
form
great
effect
viral
protein
stabil
promot
degrad
want
determin
whether
dimer
envelop
protein
would
effect
protect
reduct
disulfid
bond
dtt
pulsechas
experi
perform
bvdvinfect
mdbk
cell
cell
label
min
chase
h
absenc
dtt
time
glycoprotein
associ
homoand
heterodim
dtt
ad
cell
chase
continu
h
presenc
reduc
agent
cell
lyse
immunoprecipit
mab
bound
protein
analyz
sdspage
nonreduc
reduc
condit
fig
interestingli
intens
band
correspond
monom
reduc
approxim
dtttreat
sampl
compar
reduct
band
correspond
heterodim
see
nr
lane
better
estim
degre
overal
degrad
glycoprotein
compar
intens
correspond
band
reduc
condit
see
r
lane
scan
densitometri
analysi
show
minor
proport
protein
degrad
approxim
h
dtt
treatment
postdim
format
contrast
h
dtt
treatment
monom
result
signific
degrad
see
fig
therefor
envelop
protein
assembl
dimer
conform
complex
disulfid
bond
becom
resist
disrupt
dtt
assembl
process
viral
glycoprotein
function
oligomer
structur
part
complex
pathway
start
fold
monomer
polypeptid
compon
er
host
cell
stringent
qualiti
control
perform
organel
bvdv
heterodim
repres
major
probabl
function
compon
matur
virion
coval
link
via
disulfid
bond
rate
limit
step
assembl
heterodim
fold
occur
slowli
undergo
rapid
presum
cotransl
intramolecular
oxid
er
releas
interact
calnexin
two
glycoprotein
interact
form
disulfid
bondlink
heterodim
paper
investig
contribut
coand
posttransl
form
disulfid
bond
fold
matur
bvdv
envelop
glycoprotein
reduc
agent
dtt
chosen
tool
interfer
disulfid
bond
differ
step
protein
fold
bvdv
matur
synthesi
presenc
dtt
sever
viral
protein
influenza
haemaglutinin
ha
coronaviru
glycoprotein
abl
acquir
conformationsensit
epitop
transport
compet
system
dtt
treatment
translat
led
massiv
reduct
amount
viral
protein
accumul
puls
suggest
format
cotransl
disulfid
bond
crucial
achiev
stabl
conform
glycoprotein
failur
form
bond
could
lead
abnorm
fold
molecul
rapidli
degrad
determin
fate
monom
assembl
oligomer
prevent
perform
postpuls
dtt
treatment
experi
approach
allow
proper
oxid
monom
prevent
disulfid
bond
format
shown
sever
viral
well
cellular
protein
acquir
dtt
resist
fold
taken
place
interestingli
reduct
disulfid
bond
bvdv
monom
prevent
oligomer
process
result
degrad
result
suggest
stage
envelop
protein
biosynthesi
fold
complet
therefor
disrupt
disulfid
bond
final
fold
achiev
result
disord
structur
similar
found
format
bond
inhibit
cotransl
confirm
earlier
result
cotransl
form
disulfid
bond
crucial
subsequ
fold
bvdv
glycoprotein
nativ
form
idea
support
data
use
proteasom
inhibitor
nalln
lactacystin
strongli
inhibit
degrad
reduc
suggest
dttinduc
modif
protein
lead
recogn
misfold
er
qualiti
control
target
proteasom
like
misfold
protein
hypothesi
confirm
use
ermannosidas
inhibitor
prevent
format
man
glcnac
glycoprotein
prerequisit
target
misfold
glycoprotein
proteasomemedi
degrad
inde
data
show
inhibit
er
mannosidas
dmj
greatli
impair
degrad
directli
involv
activ
regul
dispos
unfold
bvdv
envelop
glycoprotein
interest
find
emerg
work
dtt
littl
effect
glycoprotein
assembl
dimer
word
dimer
result
conform
render
disulfid
inaccess
dtt
conclus
studi
provid
molecular
evid
disulfid
bond
play
critic
role
fold
stabil
bvdv
glycoprotein
forc
viral
protein
adopt
reduc
conform
differ
stage
viru
matur
process
result
failur
acquir
stabl
conform
led
proteasomemedi
degrad
interest
note
antivir
iminosugar
nbutyldeoxynojirimycin
eraglucosidas
inhibitor
induc
misfold
bvdv
glycoprotein
associ
least
one
disulfidebond
epitop
although
case
viral
protein
roughli
misfold
degrad
er
assembl
heterodim
impair
suggest
proper
disulfid
bond
import
achiev
nativ
conform
monom
would
enabl
subsequ
assembl
function
heterodim
